Clinical Trials Directory

Trials / Sponsors / Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics

Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics

Industry · 7 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingAleniglipron Phase 2 in Type 2 Diabetes Mellitus
Obese, Obesity, Obesity Type 2 Diabetes Mellitus
Phase 22025-12-01
Active Not RecruitingAleniglipron Phase 2 Body Composition Study
Obesity, Overweight, or Chronic Weight Management
Phase 22025-08-15
Active Not RecruitingA Dose-Range Study of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least
Obesity, Overweight, Chronic Weight Management
Phase 22024-12-20
Active Not RecruitingA Phase 2b, Dose-range Finding Study of the Efficacy and Safety of Multiple Doses of Aleniglipron (GSBR-1290)
Obesity, Overweight, or Chronic Weight Management
Phase 22024-10-17
UnknownA Study of Multiple-ascending Doses of GSBR-1290 in Healthy Overweight/Obese Participants
Healthy Volunteers
Phase 12023-10-02
CompletedA Study of Multiple Ascending Doses of GSBR-1290 in Japanese and Non-Japanese Healthy Participants
Healthy Volunteers
Phase 12023-04-24
CompletedPhase 1b/2a Study of GSBR-1290 in Adult Overweight or Obese Healthy Subjects and Subjects With Type 2 Diabetes
Overweight or Obesity, Type2 Diabetes Mellitus
Phase 1 / Phase 22023-01-09